In recent years, Iowa’s reproductive healthcare landscape has shifted, largely due to legislative moves that curtailed abortion access. Now, with the 2026 legislative session on the horizon, lawmakers and advocates are turning their attention to medication abortions, specifically the abortion pill.

The Food and Drug Administration’s recent decision to approve a new generic abortion pill has elicited strong backlash from conservative groups. Their anger reflects broader tensions over the future of medication abortion and access to reproductive health care.